Filter
1817
Filtered Results: 1817
Text search:
epidemiological
profile
Featured
Recommendations
163
New Publications
464
Language
Document type
No document type
1012
Studies & Reports
310
Guidelines
285
Strategic & Response Plan
87
Manuals
70
Fact sheets
27
Situation Updates
12
Training Material
11
Resource Platforms
3
Countries / Regions
India
79
Global
73
Western and Central Europe
64
Latin America and the Carribbean
49
Sierra Leone
39
Africa
38
Kenya
35
Nigeria
32
Brazil
32
Eastern Europe
31
Ethiopia
29
South Africa
28
Paraguay
28
Mozambique
24
Liberia
23
Uganda
23
Nepal
23
Ghana
21
Malawi
20
Myanmar / Burma
19
Zambia
18
Rwanda
18
Bangladesh
17
Argentina
16
Colombia
16
Philippines
15
Namibia
14
Guinea
13
Tanzania
13
Ukraine
13
Bolivia
13
Asia
13
Pakistan
12
Indonesia
11
Russia
11
Senegal
10
Congo, Democratic Republic of
10
Botswana
10
Venezuela
10
Syria
9
East and Southern Africa
9
South–East Asia Region
9
Eastern Europe and Central Asia
9
Zimbabwe
8
West and Central Africa
8
Afghanistan
7
Cambodia
7
Benin
7
Angola
7
Tajikistan
7
Haiti
6
Germany
6
Peru
6
Eswatini/ Swaziland
6
Lesotho
6
Middle East and North Africa
6
Albania
6
Guinea-Bissau
5
Cameroon
5
Ecuador
5
Madagascar
5
Somalia
4
El Salvador
4
Western Pacific Region
4
Iraq
3
Jordan
3
Lebanon
3
Sudan
3
Yemen
3
Georgia
3
North America
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Togo
2
Chad
2
Thailand
2
Gambia
2
Central African Republic
2
Burundi
2
Libya
2
Chile
2
Armenia
2
Southern Africa
2
Estonia
2
Moldova
2
Iran
2
Kyrgyzstan
2
Vietnam
2
Uruguay
2
Spain
2
Bosnia and Herzegovina
2
Burkina Faso
1
Morocco
1
Turkey
1
Egypt
1
China
1
Mauritania
1
Ireland
1
North Macedonia
1
Honduras
1
Greece
1
Guatemala
1
Sri Lanka
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Kazakhstan
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
698
Clinical Guidelines
194
Public Health
111
Women & Child Health
49
Key Resources
44
Pharmacy & Technologies
18
Capacity Building
15
Toolboxes
COVID-19
191
TB
186
HIV
155
Mental Health
135
Rapid Response
82
NTDs
80
AMR
58
NCDs
51
Ebola
41
Planetary Health
40
Pharmacy
23
Polio
20
Zika
20
Disability
19
Refugee
19
Conflict
16
Global Health Education
15
Cholera
13
Caregiver
13
Natural Hazards
10
Health Financing Toolbox
10
Specific Hazards
4
Social Ethics
1
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
Management of a cholera epidemic
recommended
Practical guide for doctors, nurses,laboratory technicians, medical auxiliaries,water and sanitation specialists and logisticians
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
A Resource Guide for Country Offices
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
2nd edition, June 2021
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
This manual describes methods for investigating clusters or outbreaks that may be of chemical origin and describes the importance of a structured, coordinated, collaborative multidisciplinary, multi-agency approach at local, regional, national and international levels.
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems and structures for zoonotic disease detection and control. We partnered with the government ministries resp...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
